We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics


Develops, manufactures, and distributes diagnostic systems for clinical chemistry and immunoturbidimetry. Supplies hi... read more Featured Products: More products

Download Mobile App

DiaSys Showcases High Quality Diagnostic Reagents and System Solutions

By LabMedica International staff writers
Posted on 14 Nov 2023
Print article
Image: DiaSys is present at MEDICA 2023 at Stand F80 in Hall 3 (Photo courtesy of DiaSys)
Image: DiaSys is present at MEDICA 2023 at Stand F80 in Hall 3 (Photo courtesy of DiaSys)

DiaSys Diagnostic Systems GmbH (Holzheim, Germany) is presenting its comprehensive portfolio of clinical chemistry analyzers, reagents, calibrators and controls at MEDICA 2023.

DiaSys offers complete system solutions including analyzer, reagents, and software. At MEDICA 2023, DiaSys is highlighting the respons910 benchtop analyzer which has a throughput of 100 to 150 tests/hour and is ideal for laboratories with a test volume of up to 500 tests per shift. Its high onboard capacity of 30 different methods in mono- or twin-containers and 30 sample positions offers the necessary flexibility for everyday use. Alongside the respons910, DiaSys is showcasing the respons920 benchtop analyzer with higher speed and guaranteed throughput of 200 tests/h and 360 tests/hour with ISE. With an on-board capacity of 30 different methods in mono- or twin containers, 30 samples plus nine positions for calibrators, controls, or emergency samples, respons920 offers almost unlimited flexibility in organizing laboratory workflows.

DiaSys is also highlighting the respons940 automated random access clinical chemistry analyzer that offers a constant throughput of a minimum of 400 tests/h, independent of whether a mono- or two-component reagent is used. Together with modern software features, pre-programmed applications, and carry-over evasion lists, respons940 analyzer delivers high-quality results for a broad parameter portfolio. Among the company’s products being highlighted at the show is the DiaSys CRP FS liquid-stable immunoturbidimetric test with dedicated ready-to-use calibrators and controls that allow true differentiation of borderline cases. DiaSys has extended its cardiovascular risk assessment portfolio with two innovative new reagents, HDL-c direct FS and LDL-c direct FS. Both are homogenous assays for direct determination. DiaSys has also expanded the application range for its Total bile acids 21 FS reagent and now offers the assay for use in serum and stool samples.

Related Links:
DiaSys Diagnostic Systems

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic ELISA Workstation

Print article


Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more


view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.